Translate
Bioporto
About
Bioporto (PINK:THOXF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
Major Shareholder Announcement
Apr 8 2026
BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC
Mar 31 2026
BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis
Mar 26 2026
BioPorto announces the Annual Report for 2025
Mar 18 2026
BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026
Financials
Revenue
$40.29 M
Market Cap
$73.77 M
EPS
-0.02